PPB - Services

Complaints, Feedback and Enquiry

Notice on Commencement of Mandatory Therapeutic Equivalence Demonstration For Multisource (Generic) Medical Products in Kenya

[featured_image]
  • Version
  • Download 394
  • File Size 2.72 MB
  • File Count 1
  • Create Date October 20, 2023
  • Last Updated October 20, 2023

Notice on Commencement of Mandatory Therapeutic Equivalence Demonstration For Multisource (Generic) Medical Products in Kenya

The Pharmacy and Poisons Board (hereinafter referred to as "the Board"), is mandated, under Section 3B(2)(b) of the Pharmacy and Poisons Act (Cap. 244), to ensure that all medical products manufactured in, imported into, or exported from Kenya conform to prescribed standards of quality, safety, and efficacy.

Attached Files

FileAction
Notice on Commencement of Mandatory Therapeutic Equivalence Demonstration For Multisource (Generic) Medical Products in Kenya.pdfDownload

Author

Tony Kemboi

Leave a comment

Your email address will not be published. Required fields are marked *